New migraine prevention pill tested in large chinese trial
NCT ID NCT05810038
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether the drug rimegepant can help prevent migraines in Chinese adults. 787 participants took either rimegepant or a placebo every other day for 12 weeks. The main goal was to see if rimegepant reduced the number of migraine days per month compared to placebo. The trial is now complete, and results will show if rimegepant is a safe and effective option for migraine prevention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rimegepant
What this could lead to
If successful, this could provide a new preventive treatment option for people with migraines, reducing the number of migraine days per month.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. The drug may not work better than placebo, and side effects are possible. It only tested in Chinese participants, so results may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Jiangsu University
Zhenjiang, Jiangsu, 212001, China
-
Affiliated Hospital of Jining Medical University
Jining, Shandong, 272000, China
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050, China
-
Chinese PLA General Hospital
Beijing, Beijing Municipality, 100853, China
-
Chongqing University Three Gorges Hospital
Chongqing, 404000, China
-
First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, 650032, China
-
General Hospital of Ningxia Medical Hospital
Yinchuan, Ningxia, 750003, China
-
Guangzhou First People's Hospital
Guangzhou, Guangdong, 510180, China
-
Hainan General Hospital
Haikou, Hainan, 570311, China
-
Hebei General Hospital
Shijiazhuang, Hebei, 050051, China
-
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, 046000, China
-
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, 200040, China
-
Jinan Central Hospital
Jinan, Shandong, 250013, China
-
Lanzhou university second hospital
Lanzhou, Gansu, 730030, China
-
Liaocheng people's Hospital
Liaocheng, Shandong, 252000, China
-
Linyi People's Hospital
Linyi, Shandong, 276034, China
-
Peking University People's Hospital
Beijing, 100044, China
-
People's Hospital of Rizhao
Rizhao, Shandong, 276800, China
-
People's Hospital of Zhengzhou
Zhengzhou, Henan, 450014, China
-
Pingxiang People's Hospital
Pingxiang, Jiangxi, 337055, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
-
Qingdao Central Hospital
Qingdao, Shandong, 266042, China
-
Renmin Hospital of Wuhan University
Wuhan, Hubei, 430060, China
-
Shaanxi Provincial People's Hospital
Xi'an, Shaanxi, 710068, China
-
Shanghai East Hospital
Shanghai, Shanghai Municipality, 200123, China
-
Shengli Oilfield Central Hospital
Dongying, Shandong, 257099, China
-
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, 310016, China
-
Subei People's Hospital of Jiangsu province
Yangzhou, Jiangsu, 225001, China
-
The 900th Hospital of Joint Logistics Support Force, PLA
Fuzhou, Fujian, 350025, China
-
The First Affiliated Hospital of Baotou Medical College
Baotou, Inner Mongolia, 014010, China
-
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400016, China
-
The First Affiliated Hospital of Suzhou University
Suzhou, Jiangsu, 215006, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710061, China
-
The First Affiliated Hosptial of Wenzhou Medical University
Wenzhou, Zhejiang, 325000, China
-
The First Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
-
The First hospital of Jilin University
Changchun, Jilin, 130000, China
-
The People's Hospital of Liaoning Province
Shenyang, Liaoning, 110067, China
-
The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, 210011, China
-
The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215004, China
-
The Second Affiliated hospital of Kunming Medical University
Kunming, Yunnan, 650000, China
-
The Second Hospital of Jilin University
Changchun, Jilin, 130000, China
-
The Second People's Hospital of Lianyungang
Lianyungang, Jiangsu, 222002, China
-
The Second People's hospital of Hefei
Hefei, Anhui, 230011, China
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
-
The fourth people's hospital of chongqing
Chongqing, Chongqing Municipality, 400010, China
-
Tianjin Union Medical Center
Tianjin, 300000, China
-
Wuxi No. 2 People's Hospital
Wuxi, Jiangsu, 214043, China
-
Wuxi People's Hospital
Wuxi, Jiangsu, 214023, China
-
Xianyang Hospital of Yan'an University
Xianyang, Shaanxi, 712000, China